Region 1 |
Type: | Disordered |
Name: | U-90600F |
Location: | 31 - 59 |
Length: | 29 |
Region sequence: |
YADAIFTNSYRKVLGQLSARKLLQDIMNR |
Modification type: | Engineered
Fragment
Mutant
|
PDB: | |
Structural/functional type: | Function arises via a disorder to order transition |
Functional classes: | |
Functional subclasses: | |
Detection methods:
- Fourier transform infrared spectroscopy (FTIR), aka infrared spectroscopy) (323 K; pH: 5.6; Protein (100 mg/ml))
- Fourier transform infrared spectroscopy (FTIR), aka infrared spectroscopy) (513 K; pH: 5.6; Protein (100 mg/ml))
- Fourier transform infrared spectroscopy (FTIR), aka infrared spectroscopy) (297 K; pH: 5.6; Protein (100 mg/ml))
- Fourier transform infrared spectroscopy (FTIR), aka infrared spectroscopy) (278 K; pH: 5.6; Protein (100 mg/ml))
- Raman optical activity (313 K; )
|
References:
- Sarver RW Jr, Friedman AR, Thamann TJ. "Spectroscopic studies on the conformational transitions of a bovine growth hormone releasing factor analog." Spectrochim Acta A Mol Biomol Spectrosc. 1997; 53A(11): 1889-900. PubMed: 9375414
|
Comments:U-90699F is an analog of the bovine growth hormone releasing factor. It is a fragment that contains the following substitutions: Ile32, Ser38, Ala45, Leu57, and Ser58. It also has a C-terminal tag of Hse-NH-ethyl x Ch3COOH.
|